Prism Biolab Co. Ltd (206A) Press Release
[Summary] Non-consolidated Financial Results for the Nine Months of the Fiscal Year Ending September 30, 2026 (Under Japanese GAAP)
Earlier from Prism Biolab
- PRISM BioLab and Receptor.AI Announce Drug Discovery Collaboration Agreement
- PRISM BioLab and Talus Bioscience Join Forces to Discover Novel Inhibitors of Transcription Factor and Protein-Protein Interaction Targets
- PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.